Advanced Medical Solutions Group plc (AMS) - Net Assets
Based on the latest financial reports, Advanced Medical Solutions Group plc (AMS) has net assets worth GBX260.10 Million GBX (≈ $31.65K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX394.77 Million ≈ $48.03K USD) and total liabilities (GBX134.67 Million ≈ $16.38K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Advanced Medical Solutions Group plc to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX260.10 Million |
| % of Total Assets | 65.89% |
| Annual Growth Rate | 13.56% |
| 5-Year Change | 22.3% |
| 10-Year Change | 107.21% |
| Growth Volatility | 36.98 |
Advanced Medical Solutions Group plc - Net Assets Trend (1994–2025)
This chart illustrates how Advanced Medical Solutions Group plc's net assets have evolved over time, based on quarterly financial data. See AMS days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Advanced Medical Solutions Group plc (1994–2025)
The table below shows the annual net assets of Advanced Medical Solutions Group plc from 1994 to 2025. For live valuation and market cap data, see market value of Advanced Medical Solutions Group plc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | GBX260.10 Million ≈ $31.65K |
+7.70% |
| 2024-12-31 | GBX241.52 Million ≈ $29.39K |
-1.10% |
| 2023-12-31 | GBX244.20 Million ≈ $29.71K |
+3.20% |
| 2022-12-31 | GBX236.62 Million ≈ $28.79K |
+11.26% |
| 2021-12-31 | GBX212.68 Million ≈ $25.88K |
+5.18% |
| 2020-12-31 | GBX202.21 Million ≈ $24.60K |
+5.74% |
| 2019-12-31 | GBX191.24 Million ≈ $23.27K |
+10.72% |
| 2018-12-31 | GBX172.72 Million ≈ $21.02K |
+13.31% |
| 2017-12-31 | GBX152.44 Million ≈ $18.55K |
+21.44% |
| 2016-12-31 | GBX125.53 Million ≈ $15.27K |
+21.10% |
| 2015-12-31 | GBX103.66 Million ≈ $12.61K |
+11.40% |
| 2014-12-31 | GBX93.05 Million ≈ $11.32K |
+8.09% |
| 2013-12-31 | GBX86.09 Million ≈ $10.47K |
+16.81% |
| 2012-12-31 | GBX73.70 Million ≈ $8.97K |
+11.31% |
| 2011-12-31 | GBX66.21 Million ≈ $8.06K |
+138.17% |
| 2010-12-31 | GBX27.80 Million ≈ $3.38K |
+21.66% |
| 2009-12-31 | GBX22.85 Million ≈ $2.78K |
+14.87% |
| 2008-12-31 | GBX19.89 Million ≈ $2.42K |
+26.33% |
| 2007-12-31 | GBX15.75 Million ≈ $1.92K |
+20.67% |
| 2006-12-31 | GBX13.05 Million ≈ $1.59K |
+10.15% |
| 2005-12-31 | GBX11.85 Million ≈ $1.44K |
+2.36% |
| 2004-12-31 | GBX11.57 Million ≈ $1.41K |
-3.58% |
| 2003-12-31 | GBX12.00 Million ≈ $1.46K |
-14.91% |
| 2002-12-31 | GBX14.11 Million ≈ $1.72K |
+17.62% |
| 2001-12-31 | GBX11.99 Million ≈ $1.46K |
-10.85% |
| 2000-12-31 | GBX13.45 Million ≈ $1.64K |
+40.29% |
| 1999-12-31 | GBX9.59 Million ≈ $1.17K |
-34.91% |
| 1998-12-31 | GBX14.73 Million ≈ $1.79K |
+61.99% |
| 1997-12-31 | GBX9.10 Million ≈ $1.11K |
+79.64% |
| 1996-12-31 | GBX5.06 Million ≈ $616.02 |
+116.37% |
| 1995-12-31 | GBX2.34 Million ≈ $284.71 |
-53.61% |
| 1994-12-31 | GBX5.04 Million ≈ $613.71 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Advanced Medical Solutions Group plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 18723300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | GBX184.64 Million | 71.35% |
| Common Stock | GBX10.98 Million | 4.24% |
| Other Comprehensive Income | GBX25.33 Million | 9.79% |
| Other Components | GBX37.84 Million | 14.62% |
| Total Equity | GBX258.79 Million | 100.00% |
Advanced Medical Solutions Group plc Competitors by Market Cap
The table below lists competitors of Advanced Medical Solutions Group plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
North Atlantic Smaller Companies Investment Trust PLC
LSE:NAS
|
$6.21 Million |
|
Da Lue International Holding Co Ltd
TWO:4804
|
$6.21 Million |
|
FIN Resources Ltd
AU:FIN
|
$6.22 Million |
|
EMU NL
AU:EMU
|
$6.22 Million |
|
Priti International Limited
NSE:PRITI
|
$6.21 Million |
|
Princess Private Equity Holding Ltd
LSE:PEYS
|
$6.21 Million |
|
Wilk Technologies Ltd
TA:WILK
|
$6.21 Million |
|
Austin Metals Ltd
AU:AYT
|
$6.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Advanced Medical Solutions Group plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 240,777,000 to 258,791,000, a change of 18,014,000 (7.5%).
- Net income of 9,954,000 contributed positively to equity growth.
- Dividend payments of 5,791,000 reduced retained earnings.
- New share issuances of 329,000 increased equity.
- Other comprehensive income increased equity by 8,101,000.
- Other factors increased equity by 5,421,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX9.95 Million | +3.85% |
| Dividends Paid | GBX5.79 Million | -2.24% |
| Share Issuances | GBX329.00K | +0.13% |
| Other Comprehensive Income | GBX8.10 Million | +3.13% |
| Other Changes | GBX5.42 Million | +2.09% |
| Total Change | GBX- | 7.48% |
Book Value vs Market Value Analysis
This analysis compares Advanced Medical Solutions Group plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 199.78x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 1025.95x to 199.78x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-12-31 | GBX0.23 | GBX235.00 | x |
| 1995-12-31 | GBX0.09 | GBX235.00 | x |
| 1996-12-31 | GBX0.15 | GBX235.00 | x |
| 1997-12-31 | GBX0.24 | GBX235.00 | x |
| 1998-12-31 | GBX0.34 | GBX235.00 | x |
| 1999-12-31 | GBX0.14 | GBX235.00 | x |
| 2000-12-31 | GBX0.14 | GBX235.00 | x |
| 2001-12-31 | GBX0.13 | GBX235.00 | x |
| 2002-12-31 | GBX0.11 | GBX235.00 | x |
| 2003-12-31 | GBX0.08 | GBX235.00 | x |
| 2004-12-31 | GBX0.08 | GBX235.00 | x |
| 2005-12-31 | GBX0.08 | GBX235.00 | x |
| 2006-12-31 | GBX0.09 | GBX235.00 | x |
| 2007-12-31 | GBX0.10 | GBX235.00 | x |
| 2008-12-31 | GBX0.13 | GBX235.00 | x |
| 2009-12-31 | GBX0.15 | GBX235.00 | x |
| 2010-12-31 | GBX0.18 | GBX235.00 | x |
| 2011-12-31 | GBX0.41 | GBX235.00 | x |
| 2012-12-31 | GBX0.35 | GBX235.00 | x |
| 2013-12-31 | GBX0.41 | GBX235.00 | x |
| 2014-12-31 | GBX0.44 | GBX235.00 | x |
| 2015-12-31 | GBX0.49 | GBX235.00 | x |
| 2016-12-31 | GBX0.59 | GBX235.00 | x |
| 2017-12-31 | GBX0.71 | GBX235.00 | x |
| 2018-12-31 | GBX0.80 | GBX235.00 | x |
| 2019-12-31 | GBX0.88 | GBX235.00 | x |
| 2020-12-31 | GBX0.93 | GBX235.00 | x |
| 2021-12-31 | GBX0.97 | GBX235.00 | x |
| 2022-12-31 | GBX1.08 | GBX235.00 | x |
| 2023-12-31 | GBX1.11 | GBX235.00 | x |
| 2024-12-31 | GBX1.10 | GBX235.00 | x |
| 2025-12-31 | GBX1.18 | GBX235.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Advanced Medical Solutions Group plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.35%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 1.53x
- Recent ROE (3.85%) is above the historical average (-7.12%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | -34.42% | -5260.61% | 0.01x | 1.16x | GBX-2.24 Million |
| 1995 | -115.56% | -1445.99% | 0.06x | 1.41x | GBX-2.94 Million |
| 1996 | -78.75% | -276.11% | 0.23x | 1.26x | GBX-4.49 Million |
| 1997 | -61.43% | -170.86% | 0.23x | 1.54x | GBX-6.50 Million |
| 1998 | -33.41% | -91.39% | 0.30x | 1.21x | GBX-6.40 Million |
| 1999 | -53.76% | -82.88% | 0.51x | 1.27x | GBX-6.12 Million |
| 2000 | -19.96% | -34.37% | 0.49x | 1.19x | GBX-4.03 Million |
| 2001 | -12.26% | -19.94% | 0.53x | 1.17x | GBX-2.67 Million |
| 2002 | -9.90% | -16.69% | 0.51x | 1.16x | GBX-2.81 Million |
| 2003 | -17.36% | -23.12% | 0.62x | 1.21x | GBX-3.28 Million |
| 2004 | -3.60% | -3.78% | 0.80x | 1.20x | GBX-1.57 Million |
| 2005 | 2.33% | 2.14% | 0.90x | 1.21x | GBX-908.70K |
| 2006 | 5.72% | 5.22% | 0.89x | 1.23x | GBX-557.90K |
| 2007 | 14.20% | 13.27% | 0.88x | 1.22x | GBX661.40K |
| 2008 | 16.63% | 16.29% | 0.83x | 1.23x | GBX1.32 Million |
| 2009 | 12.18% | 11.56% | 0.81x | 1.30x | GBX499.00K |
| 2010 | 17.38% | 15.16% | 0.97x | 1.19x | GBX2.05 Million |
| 2011 | 7.32% | 14.12% | 0.35x | 1.50x | GBX-1.77 Million |
| 2012 | 13.15% | 18.43% | 0.54x | 1.32x | GBX2.32 Million |
| 2013 | 13.20% | 19.10% | 0.61x | 1.13x | GBX2.76 Million |
| 2014 | 13.82% | 20.42% | 0.60x | 1.12x | GBX3.56 Million |
| 2015 | 13.62% | 20.58% | 0.59x | 1.12x | GBX3.75 Million |
| 2016 | 12.50% | 18.85% | 0.57x | 1.16x | GBX3.14 Million |
| 2017 | 13.21% | 20.78% | 0.57x | 1.11x | GBX4.89 Million |
| 2018 | 13.11% | 22.08% | 0.50x | 1.19x | GBX5.38 Million |
| 2019 | 9.89% | 18.48% | 0.45x | 1.19x | GBX-204.50K |
| 2020 | 4.25% | 9.89% | 0.36x | 1.18x | GBX-11.64 Million |
| 2021 | 8.22% | 16.10% | 0.44x | 1.17x | GBX-3.79 Million |
| 2022 | 8.62% | 16.41% | 0.44x | 1.19x | GBX-3.26 Million |
| 2023 | 6.51% | 12.59% | 0.44x | 1.18x | GBX-8.53 Million |
| 2024 | 2.95% | 4.00% | 0.46x | 1.62x | GBX-16.98 Million |
| 2025 | 3.85% | 4.35% | 0.58x | 1.53x | GBX-15.93 Million |
Industry Comparison
This section compares Advanced Medical Solutions Group plc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $-699,289,442
- Average return on equity (ROE) among peers: 6.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Advanced Medical Solutions Group plc (AMS) | GBX260.10 Million | -34.42% | 0.52x | $6.21 Million |
| ConvaTec Group PLC (CTEC) | $-2.13 Billion | 0.00% | 0.00x | $49.10 Million |
| Inspecs Group plc (SPEC) | $22.71 Million | 15.40% | 2.05x | $1.24 Million |
| Tristel (TSTL) | $11.92 Million | 3.99% | 0.17x | $2.26 Million |
About Advanced Medical Solutions Group plc
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It offers surgical products, such as tissue adhesives, sutures and clips, haemostats, biosurgical, internal fixation devices, infection c… Read more